4.6 Review

Vitamin D supplementation for irritable bowel syndrome: A systematic review and meta-analysis

期刊

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
卷 37, 期 6, 页码 993-1003

出版社

WILEY
DOI: 10.1111/jgh.15852

关键词

IBS severity score; irritable bowel syndrome; quality of life; symptom management; vitamin D

向作者/读者索取更多资源

This systematic review and meta-analysis found that vitamin D supplementation can significantly improve the severity of IBS symptoms, but the improvement in quality of life is not statistically significant. However, limitations such as small sample sizes, a relatively young study population, limited ethnicities, and varied vitamin D dosing strategies across the studies should be noted.
Background and Aim Irritable bowel syndrome (IBS) is a prevalent and complex gastrointestinal disorder characterized by chronic abdominal pain and altered bowel habits. Observational studies have suggested a relationship between serum vitamin D levels and IBS symptoms. This systematic review and meta-analysis aimed to investigate the clinical effects of vitamin D supplementation on IBS symptom severity and quality of life (QoL) measures. Methods Medline, Embase, Scopus, Web of Science, and The Cochrane Library databases were systematically searched. Data abstraction and quality assessment were conducted by four authors independently, and discrepancies were resolved through consensus from the senior author. Continuous data were pooled with standardized mean difference (SMD) using the DerSimonian and Laird's random-effects model. Sensitivity analysis by risk of bias and potentially predatory publication were performed as well. Results A total of 685 patients across eight studies were included in the meta-analysis. Vitamin D supplementation significantly improved IBS symptom severity scale scores, with a SMD of -0.77 (95% confidence interval [CI] -1.47 to -0.07, P = 0.04, I-2 = 91%). Improvements in IBS-QoL scores were also observed, albeit not statistically significant (SMD 0.54; 95% CI -0.34 to 1.41, P = 0.15, I-2 = 87%). However, small sample sizes, a relatively young study population, limited ethnicities, and varied vitamin D dosing strategies across the studies were notable limitations. Conclusions Vitamin D supplementation could be part of our clinical armamentarium when managing IBS patients due to the potential efficacy and good safety profile. Further randomized, controlled trials are required to confirm the therapeutic effects.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据